Glycemic variability (GV), defined as an integral component of glucose homoeostasis, is
emerging as an important metric to consider when assessing glycemic control in clinical …

C-peptide is a widely used measure of pancreatic beta cell function. It is produced in
equimolar amounts to endogenous insulin but is excreted at a more constant rate over a …

Diabetes is the most prevalent long-term condition, occurring in approximately 6.5% of the
UK population. However, an average of 18% of all acute hospital beds are occupied by …

Background: Tens of glycemic variability (GV) indices are available in the literature to
characterize the dynamic properties of glucose concentration profiles from continuous …

Background Glucose variability is common among hospitalized patients, but the prognostic
implications among patients hospitalized in surgical wards are unknown. The objective of …

Objective To determine the role of hypoglycemia, hyperglycemia or the combination of both
as independent risk factors for falls in a hospital population. Secondary objectives included …

Objective. Type 2 diabetes mellitus (T2DM) is known to be associated with increased
cardiovascular risk. The aim of this study was therefore to investigate the independent …

Aims Previous evidence has demonstrated that participation in the Dose Adjustment for
Normal Eating (DAFNE) education programme can reduce HbA1c and severe …

Diabetes is associated with substantially increased mortality. Classic risk factors explain a
portion of the excess of mortality in type 2 diabetes. The aim of this study was to examine …

Context Glycemic variability and hypoglycemia during diabetes treatment may impact
therapeutic effectiveness and safety, even when glycated hemoglobin (HbA1c) reduction is …